glp 1 and gip dual agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Effects, working principles and target

Iatrogenic hyperinsulinemia, not hyperglycemia, drives insulin resistance in type 1 diabetes as revealed by comparison with GCK-MODY (MODY2)

Concomitant glucose-lowering medications were also different between the groups before matching, with a lower proportion of individuals on oral medications and more on insulin in the SGLT2i group

For those on semaglutide, similar dietary principles apply

Wegovy lawsuits are being pursued for individuals throughout the United States who were hospitalized due to significant gastrointestinal problems or suffered vision problems after using the weight loss drug

The Berberine Belly and Safety The most common issue is GI upset